טוען...

CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response

Predicting the response and identifying additional targets that will improve the efficacy of chemotherapy is a major goal in cancer research. Through large-scale in vivo and in vitro CRISPR knockout screens in pancreatic ductal adenocarcinoma cells, we identified genes whose genetic deletion or phar...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Nat Commun
Main Authors: Szlachta, Karol, Kuscu, Cem, Tufan, Turan, Adair, Sara J., Shang, Stephen, Michaels, Alex D., Mullen, Matthew G., Fischer, Natasha Lopes, Yang, Jiekun, Liu, Limin, Trivedi, Prasad, Stelow, Edward B., Stukenberg, P. Todd, Parsons, J. Thomas, Bauer, Todd W., Adli, Mazhar
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6189038/
https://ncbi.nlm.nih.gov/pubmed/30323222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-06676-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!